Matches in Wikidata for { <http://www.wikidata.org/entity/Q90068787> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- Q90068787 description "artículu científicu espublizáu en xunu de 2017" @default.
- Q90068787 description "scientific article published on 01 June 2017" @default.
- Q90068787 description "wetenschappelijk artikel" @default.
- Q90068787 description "наукова стаття, опублікована в червні 2017" @default.
- Q90068787 name "Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) as perioperative treatment of resectable gastric or gastro-esophageal junction adenocarcinoma: The multicenter, rando" @default.
- Q90068787 name "Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) as perioperative treatment of resectable gastric or gastro-esophageal junction adenocarcinoma: The multicenter, rando" @default.
- Q90068787 type Item @default.
- Q90068787 label "Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) as perioperative treatment of resectable gastric or gastro-esophageal junction adenocarcinoma: The multicenter, rando" @default.
- Q90068787 label "Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) as perioperative treatment of resectable gastric or gastro-esophageal junction adenocarcinoma: The multicenter, rando" @default.
- Q90068787 prefLabel "Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) as perioperative treatment of resectable gastric or gastro-esophageal junction adenocarcinoma: The multicenter, rando" @default.
- Q90068787 prefLabel "Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) as perioperative treatment of resectable gastric or gastro-esophageal junction adenocarcinoma: The multicenter, rando" @default.
- Q90068787 P1433 Q90068787-20B44348-6DA4-48B3-91B7-9A27FD5CE3BD @default.
- Q90068787 P1476 Q90068787-C3EC16D0-120D-4B25-B4D9-437CBADB2A7F @default.
- Q90068787 P2093 Q90068787-086123AE-D68A-4862-91F1-8140169556DF @default.
- Q90068787 P2093 Q90068787-1E552012-0772-4E54-9027-B47704DB0A63 @default.
- Q90068787 P2093 Q90068787-23E32822-0BBD-4DE5-9D0D-2EB24D1E3978 @default.
- Q90068787 P2093 Q90068787-2D0C1869-A291-43B3-860B-9EA57904CBB9 @default.
- Q90068787 P2093 Q90068787-4697DFC6-5D65-46E4-ACE2-365B4833B80C @default.
- Q90068787 P2093 Q90068787-4AB0C43A-B7D8-47A4-ACC8-30A753837BD2 @default.
- Q90068787 P2093 Q90068787-4B417933-F941-4ED1-BA93-5566EB0D4E0F @default.
- Q90068787 P2093 Q90068787-4E30DBF5-178D-4506-8850-14B54EFF315B @default.
- Q90068787 P2093 Q90068787-5AF9FC76-220A-4079-AB0A-6EA36C57E892 @default.
- Q90068787 P2093 Q90068787-5BF56F7C-6E97-41C3-AF7C-527851E5E122 @default.
- Q90068787 P2093 Q90068787-725C5FFB-8FAC-4F66-BFE4-C606C5DF7D8D @default.
- Q90068787 P2093 Q90068787-785405A9-B655-4F78-B6A0-E3F50D492A8A @default.
- Q90068787 P2093 Q90068787-7B754771-CE51-4C9F-9AAB-1A2855461DB1 @default.
- Q90068787 P2093 Q90068787-8AECF1DF-7315-4D12-9741-E67D52AFB473 @default.
- Q90068787 P2093 Q90068787-8FC8171F-EEFF-4D32-AFB9-F72026E212F5 @default.
- Q90068787 P2093 Q90068787-A291A8FE-91B3-4C93-9433-2C96F2B72846 @default.
- Q90068787 P2093 Q90068787-D82C385A-1D0D-4512-9209-8B039185721F @default.
- Q90068787 P2093 Q90068787-DF238174-60C2-4466-A034-E987325A0F48 @default.
- Q90068787 P304 Q90068787-5151E51B-8FC6-4A91-8DB7-2940171C8503 @default.
- Q90068787 P31 Q90068787-55E693C3-BF94-4973-AA4E-19EF0B4C12EF @default.
- Q90068787 P356 Q90068787-E9A0C0F4-3624-4F77-BA4E-3250F48B9F3B @default.
- Q90068787 P478 Q90068787-037D81DC-CEDD-407A-AAD4-23E191063743 @default.
- Q90068787 P577 Q90068787-619846B2-C5C5-4C57-9148-95F7126CC242 @default.
- Q90068787 P921 Q90068787-61A5183B-9023-4D96-89CA-A1594EA46EE0 @default.
- Q90068787 P921 Q90068787-948B8492-59DD-4B90-8FB5-20ADA079B68C @default.
- Q90068787 P921 Q90068787-C50937DC-B4DC-4C85-A033-5A52018E6BF4 @default.
- Q90068787 P921 Q90068787-C9172F0B-4FBD-4E3B-A88E-512BB7FA6F7C @default.
- Q90068787 P356 MDX302.007 @default.
- Q90068787 P1433 Q326122 @default.
- Q90068787 P1476 "Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) as perioperative treatment of resectable gastric or gastro-esophageal junction adenocarcinoma: The multicenter, randomized phase 3 FLOT4 trial (German Gastric Group at AIO)" @default.
- Q90068787 P2093 "Barbara Luley Kim" @default.
- Q90068787 P2093 "C Thuss-Patience Peter" @default.
- Q90068787 P2093 "Claudia Pauligk" @default.
- Q90068787 P2093 "Elke Jäger" @default.
- Q90068787 P2093 "Georg Martin Haag" @default.
- Q90068787 P2093 "Gunnar Folprecht" @default.
- Q90068787 P2093 "H Schmiegel Wolff" @default.
- Q90068787 P2093 "H Schuler Martin" @default.
- Q90068787 P2093 "Hans-Georg Kopp" @default.
- Q90068787 P2093 "Harald Schmalenberg" @default.
- Q90068787 P2093 "Johannes Meiler" @default.
- Q90068787 P2093 "Jorg Trojan" @default.
- Q90068787 P2093 "Nicole Prasnikar" @default.
- Q90068787 P2093 "Nils Homann" @default.
- Q90068787 P2093 "Ralf-Dieter Hofheinz" @default.
- Q90068787 P2093 "Salah-Eddin Al-Batran" @default.
- Q90068787 P2093 "Stephan Probst" @default.
- Q90068787 P2093 "Thorsten Oliver Goetze" @default.
- Q90068787 P304 "iii152-iii153" @default.
- Q90068787 P31 Q13442814 @default.
- Q90068787 P356 "10.1093/ANNONC/MDX302.007" @default.
- Q90068787 P478 "28 Suppl 3" @default.
- Q90068787 P577 "2017-06-01T00:00:00Z" @default.
- Q90068787 P921 Q238512 @default.
- Q90068787 P921 Q420207 @default.
- Q90068787 P921 Q420436 @default.
- Q90068787 P921 Q422327 @default.